Abbott announced it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient’s blood.
Read MoreInoLife Technologies announced it will provide and market a proprietary metabolizing test to physicians and practitioners to identify how a patient’s genetic makeup may affect the body’s response to Plavix (colpidogrel).
Read MoreMolecular diagnostics business Renishaw Diagnostics Ltd, has announced the appointment of Jim Greaves as Head of Marketing.
Read MoreAn opinion piece by a legal scholar from the Johns Hopkins Berman Institute of Bioethics in this weeks issue of Nature calls for the FDA to regulate all health-related genetic tests.
Read More
Advances in genomics and biomarker identification facilitate more accurate diagnoses for cancer patients.
Read More